 Michelle Katherine Haas
| Title | Asst Professor |
|---|
| Institution | University of Colorado Denver - Anschutz Medical Campus |
|---|
| Department | SOM-MED |
|---|
|
|
|
 Bibliographic
-
Aiona K, Bacon E, Podewils LJ, Haas MK. The disparate impact of age-based COVID-19 vaccine prioritization by race/ethnicity in Denver, Colorado. Health Policy Open. 2022 Dec; 3:100074. PMID: 35892113.
-
Haas MK, Aiona K, Erlandson KM, Belknap RW. Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis. Clin Infect Dis. 2021 11 02; 73(9):e3459-e3467. PMID: 32915203.
-
Schultz J, Beeson A, Newton T, Gannon J, Frank A, Franco-Paredes C, Haas M, Venci J. Impact of An Internal Medicine-Pediatrics Residency Quality Improvement Project to Increase Latent Tuberculosis Screening. Am J Med Sci. 2021 05; 361(5):670-672. PMID: 33775427.
-
Bonfiglio G, Rosal K, Henao-Mart?nez A, Franco-Paredes C, Poeschla EM, Moo-Young J, Seefeldt T, Dunlevy H, Haas M, Young J. The long journey inside immigration detention centres in the USA. J Travel Med. 2020 11 09; 27(7). PMID: 32463091.
-
Gaensbauer J, Young J, Harasaki C, Aiona K, Belknap R, Haas MK. Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health System. Pediatr Infect Dis J. 2020 09; 39(9):803-807. PMID: 32804462.
-
Flynn AG, Aiona K, Haas MK, Reves R, Belknap R. Clinical Characteristics of Active Tuberculosis Diagnosed After Starting Treatment for Latent Tuberculosis Infection. Clin Infect Dis. 2020 08 22; 71(5):1320-1323. PMID: 31773132.
-
Haas MK, Belknap RW. Diagnostic Tests for Latent Tuberculosis Infection. Clin Chest Med. 2019 12; 40(4):829-837. PMID: 31731987.
-
Haas MK, Reves R. Strong Community-Public Health Partnerships May Help Us Move Closer to Tuberculosis Elimination. Am J Public Health. 2019 07; 109(7):958-959. PMID: 31166724.
-
Ruoff K, Kilic T, Devant J, Koromyslova A, Ringel A, Hempelmann A, Geiss C, Graf J, Haas M, Roggenbach I, Hansman G. Structural Basis of Nanobodies Targeting the Prototype Norovirus. J Virol. 2019 03 15; 93(6). PMID: 30602609.
-
Haas MK, Belknap RW. Updates in the Treatment of Active and Latent Tuberculosis. Semin Respir Crit Care Med. 2018 Jun; 39(3):297-309. PMID: 30071545.
-
Gersh JK, Feldman Z, Greenberger E, Chandra A, Friedman HM, Ho-Foster A, Haas MK. Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana. J Public Health Afr. 2018 May 21; 9(1):803. PMID: 30079172.
-
Gaensbauer J, Aiona K, Haas M, Reves R, Young J, Belknap R. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic. Pediatr Infect Dis J. 2018 03; 37(3):224-228. PMID: 28777204.
-
Pedela RL, Shihadeh KC, Knepper BC, Haas MK, Burman WJ, Jenkins TC. Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System. Infect Control Hosp Epidemiol. 2017 04; 38(4):461-468. PMID: 28052786.
-
Haas MK, Dalton K, Knepper BC, Stella SA, Cervantes L, Price CS, Burman WJ, Mehler PS, Jenkins TC. Effects of a Syndrome-Specific Antibiotic Stewardship Intervention for Inpatient Community-Acquired Pneumonia. Open Forum Infect Dis. 2016 Oct; 3(4):ofw186. PMID: 27747254.
-
Haas MK, Daley CL. Mycobacterial Lung Disease Complicating HIV Infection. Semin Respir Crit Care Med. 2016 Apr; 37(2):230-42. PMID: 26974300.
-
Yogo N, Haas MK, Knepper BC, Burman WJ, Mehler PS, Jenkins TC. Antibiotic prescribing at the transition from hospitalization to discharge: a target for antibiotic stewardship. Infect Control Hosp Epidemiol. 2015 Apr; 36(4):474-8. PMID: 25782905.
-
Jenkins TC, Knepper BC, Shihadeh K, Haas MK, Sabel AL, Steele AW, Wilson ML, Price CS, Burman WJ, Mehler PS. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol. 2015 Jun; 36(6):664-72. PMID: 25740560.
-
Reid MJ, Haas MK, Sedigeng P, Ramogola-Masire D, Friedman HM, Ho-Foster A. Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana. J Int Assoc Provid AIDS Care. 2016 Jan-Feb; 15(1):7-10. PMID: 25656859.
-
Haas MK, Levy DN, Folkvord JM, Connick E. Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo. AIDS Res Hum Retroviruses. 2015 Mar; 31(3):298-304. PMID: 25353356.
-
Jenkins TC, Haas MK, Shihadeh KC, Lavonas EJ. Trimethoprim-sulfamethoxazole for skin and soft tissue infections--let us not forget the risks. Ann Emerg Med. 2014 Jun; 63(6):783-4. PMID: 24841401.
-
Meditz AL, Haas MK, Folkvord JM, Melander K, Young R, McCarter M, Mawhinney S, Campbell TB, Lie Y, Coakley E, Levy DN, Connick E. HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo. J Virol. 2011 Oct; 85(19):10189-200. PMID: 21813616.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2011 | 1 | | 2014 | 2 | | 2015 | 3 | | 2016 | 2 | | 2017 | 1 | | 2018 | 3 | | 2019 | 3 | | 2020 | 4 | | 2021 | 1 | | 2022 | 1 |
To return to the timeline, click here.
|
Haas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|